Thursday - May 7, 2026
GSK Presents Latest Respiratory Research to Advance Patient Care at ATS 2026
May 07, 2026
LONDON, England, May 7 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release:

* * *

GSK presents latest respiratory research to advance patient care at ATS 2026

* Data for ultra-long-acting Exdensur (depemokimab) will show sustained efficacy over two years in patients with severe asthma with type 2 inflammation

* Patient preference and adherence research highlight potential of long-acting dosing regi . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products